1. SMARTphone and Social Media-Based Cardiac Rehabilitation and Secondary Prevention in China (SMART-CR/SP): A Randomised Controlled Trial
- Author
-
Lhamo Tsokey, B-K Tan, Anna Scheer, Andrew Maiorana, Yaolin Chen, Jing Wang, Gang Zhao, Angela Jacques, Khandro Tso, Zhixing Li, Ruochen Wang, Clara K Chow, Tashi Dorje, and Junbo Ge
- Subjects
Secondary prevention ,medicine.medical_specialty ,Rehabilitation ,business.industry ,medicine.medical_treatment ,Service model ,Coronary heart disease ,law.invention ,Blood pressure ,Randomized controlled trial ,law ,Internal medicine ,Medicine ,Human research ,Risk factor ,business - Abstract
Background: Coronary heart disease (CHD) is rapidly increasing in developing countries, but access to cardiac rehabilitation and secondary prevention (CR/SP) remains low. We assessed the effectiveness of SMARTphone and WeChat-based CR/SP (SMART-CR/SP) in the first randomised controlled trial (RCT) of a dedicated social media-based CR/SP program for patients with CHD. Methods: In this parallel-group, single-blind, RCT, CHD patients from a large tertiary hospital in Shanghai, China were randomised (1:1) to an eight-week 'intensive', followed by a 16-week 'step down' program of SMART-CR/SP, or usual care. Assessments were conducted at baseline, eight and 24 weeks. The primary outcome was functional capacity measured by six-minute walk test distance (6MWTD). Secondary outcomes included CHD knowledge, and risk factor control. Analysis was by intention-to-treat. Findings: Between November 17, 2016 and March 18, 2017, 312 patients (mean age, 60.5 [SD 9.2] years, 81.4% male) were randomised to SMART-CR/SP (n=156) or usual care (n=156). The mean increase in 6MWTD was greater at both eight (46.5 vs. 20.9 m; 95% CI 9.6 to 41.5; p=0.002) and 24 weeks (54.2 vs. 26.2 m; 95% CI 10.9 to 44.9; p=0.001) in the SMART-CR/SP group versus controls. The SMART-CR/SP group had a better knowledge of CHD score at eight (17.9 vs. 13.8; 95% CI 2.84 to 5.44; p
- Published
- 2019
- Full Text
- View/download PDF